AHCA/NCAL has announced that members have nearly met the goal of reducing the use of off-label antipsychotic drugs in skilled nursing center to sedate residents with dementia by 30 percent by the end of 2016.

AHCA/NCAL President and CEO Mark Parkinson lauded this achievement as a major accomplishment for providers, as well as for residents and their families. Read more here.